Fabrication of injectable alginate hydrogels with sustained release of 4-octyl itaconate for articular anti-inflammatory
Bio-Medical Materials and Engineering · 05.09.2024 · 35 (5) · 475-485
DOI: 10.3233/bme-240103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bio-Medical Materials and Engineering, erschienen am 05.09.2024. Verfasst von Ronghua Bao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Hangzhou Fuyang Hospital of TCM Orthopedics and Traumatology, Hangzhou, China. Hauptthemen laut MEDLINE: Hydrogels, Alginates, Succinates, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Osteoarthritis (OA) is a chronic and degenerative joint disease that remains a great challenge in treatment due to the lack of effective therapies. 4-octyl itaconate (4-OI) is a novel and potent modulator of inflammation for the treatment of inflammatory disease. However, the clinical usage of 4-OI is limited due to its poor solubility and low bioavailability. As a promising drug delivery strategy, injectable hydrogels offers an effective approach to address these limitations of 4-OI. OBJECTIVE: The aim of the study was to verify that the composite 4-OI/SA hydrogels could achieve a controlled release of 4-OI and reduce damage to articular cartilage in the group of osteoarthritic rats treated with the system. METHODS: In this study, an injectable composite hydrogel containing sodium alginate (SA) and 4-octyl itaconate (4-OI) has been developed for continuous intra-articular administration in the treatment of OA. RESULTS: After intra-articular injection in arthritic rats, the as-prepared 4-OI/SA hydrogel containing of 62.5 μM 4-OI effectively significantly reduced the expression of TNF-α, IL-1β, IL-6 and MMP3 in the ankle fluid. Most importantly, the as-prepared 4-OI/SA hydrogel system restored the morphological parameters of the ankle joints close to normal. CONCLUSION: 4-OI/SA hydrogel shows a good anti-inflammatory activity and reverse cartilage disruption, which provide a new strategy for the clinical treatment of OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Hangzhou Fuyang Hospital of TCM Orthopedics and Traumatology, Hangzhou, China.
- Department of Medical Research, Zhejiang Zhongwei Medical Research Co., Ltd, Hangzhou, China.
- School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, China.
Zitieren
APA
Bao, R., Mao, Y., Zhang, Y., Chai, J., Zhang, Y., Luo, C., Zhang, K., Jiang, G., & He, X. (2024). Fabrication of injectable alginate hydrogels with sustained release of 4-octyl itaconate for articular anti-inflammatory. Bio-Medical Materials and Engineering, 35(5), 475-485. https://doi.org/10.3233/bme-240103
Vancouver
Bao R, Mao Y, Zhang Y, Chai J, Zhang Y, Luo C, et al. Fabrication of injectable alginate hydrogels with sustained release of 4-octyl itaconate for articular anti-inflammatory. Bio-Medical Materials and Engineering. 2024;35(5):475-485. doi:10.3233/bme-240103
BibTeX
@article{Bao2024,
author = {Bao, Ronghua and Mao, Yifan and Zhang, Yuliang and Chai, Junlei and Zhang, Yuanbin and Luo, Cheng and Zhang, Kailong and Jiang, Guohua and He, Xiaodan},
title = {Fabrication of injectable alginate hydrogels with sustained release of 4-octyl itaconate for articular anti-inflammatory},
journal = {Bio-Medical Materials and Engineering},
year = {2024},
volume = {35},
number = {5},
pages = {475--485},
doi = {10.3233/bme-240103}
}
EUVIMED